VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit [Accessibility Statement] Skip NavigationNEW YORK, Feb. 27, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Vistagen Therapeutics, Inc. (NASDAQ: VTGN) between April 1, 2024 and December 16, 2025, both dates inclusive (the "Class Period"), of the important March 16, 2026 lead plaintiff deadline.So what: If you purchased Vistagen common s ...

PayPal Holdings, Inc. (NASDAQ:PYPL) - The class action lawsuit alleges that PayPal misled investors regarding its revenue outlook and growth potential during the class period from February 25, 2025, to February 2, 2026 [6] - PayPal's fourth quarter and full fiscal year 2025 results, announced on February 3, 2026, revealed disappointing earnings and a withdrawal of its 2027 financial targets, leading to a stock price drop of over 20% [6] - The lawsuit claims that the company's optimistic growth plans were unrealistic and that the management failed to provide clear direction, contributing to operational issues [6] REGENXBIO Inc. (NASDAQ:RGNX) - The class action lawsuit involves allegations that REGENXBIO provided misleading information about its gene therapy product candidate RGX-111 during the class period from February 9, 2022, to January 27, 2026 [6] - On January 28, 2026, REGENXBIO announced that the FDA placed a clinical hold on RGX-111 due to the discovery of an intraventricular CNS tumor in a trial participant, resulting in a 17.8% decline in stock price from $13.41 to $11.01 in one day [6] - The lawsuit claims that the company made overly positive assertions about RGX-111's trial success while concealing material adverse facts regarding its efficacy and safety [6]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased REGENXBIO, Inc. securities between February 9, 2022, and January 27, 2026, of the April 14, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased REGENXBIO securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by April 14, 2026 [3]. - The lawsuit alleges that REGENXBIO provided misleading information regarding its gene therapy product candidate RGX-111, which is intended for treating severe Mucopolysaccharidosis Type I [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms issuing notices may lack the necessary experience [4]. - The Rosen Law Firm has a history of successful settlements in securities class actions, including a record settlement against a Chinese company and significant recoveries for investors in previous years [4].

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 6, 2026 in BlackRock TCP Capital Corp. Lawsuit - TCPC [Accessibility Statement] Skip NavigationNEW YORK, Feb. 25, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in BlackRock TCP Capital Corp. ("BlackRock TCP" or the "Company") (NASDAQ: TCPC) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BlackRock TCP investors who were adversely affected by alleged securities f ...

LEVI & KORSINSKY, LLP: SECTION 10(B) AND RULE 10B-5 CLAIMS ASSERTED IN INOVIO PHARMACEUTICALS SECURITIES LITIGATION [Accessibility Statement] Skip NavigationShareholders Who Purchased INO Securities During Class Period Urged to Review OptionsNEW YORK, Feb. 25, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP announces that a securities class action has been filed against Inovio Pharmaceuticals, Inc. (NASDAQ: INO).YOU MAY BE AFFECTED IF YOU:- Acquired shares during the Class Period- Lost money on your Inovio inves ...

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of REGENXBIO, Inc. (NASDAQ: RGNX) between February 9, 2022 and January 27, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 14, 2026. SO WHAT: If you purchased REGENXBIO securities during the Class Period you may be enti ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Pomdoctor Limited (NASDAQ: POM) and reminds investors of the April 13, 2026 deadline to seek the role of lead plaintiff in a federal securities class action filed against the company [1] Group 1: Allegations Against Pomdoctor - The complaint alleges that Pomdoctor and its executives violated federal securities laws by making false and/or misleading statements and failing to disclose critical information [1] - Specific allegations include involvement in a fraudulent stock promotion scheme, use of offshore accounts for share dumping, and omission of false rumors affecting stock price [1] - The company's public statements were deemed materially misleading and lacked a reasonable basis due to these omissions [1] Group 2: Stock Performance - Pomdoctor's share price experienced a significant decline from approximately $0.50 per share on December 10, 2025, to about $0.38 per share on December 11, 2025, marking a decline of roughly $0.12 per share or approximately 24% in a single trading session [1] - This decline followed increased volatility and selling pressure amid broader investor concerns regarding Pomdoctor's financial performance and valuation [1] Group 3: Legal Proceedings - The court-appointed lead plaintiff is defined as the investor with the largest financial interest in the relief sought by the class, who will oversee the litigation on behalf of the class members [1] - Any member of the putative class may move the Court to serve as lead plaintiff or choose to remain an absent class member without affecting their ability to share in any recovery [1]

Core Viewpoint - Masonite International Corporation is facing a class action lawsuit for securities law violations, specifically for making false and misleading statements regarding its share repurchase activities while in possession of acquisition offers from Owens Corning at higher prices [1]. Group 1: Lawsuit Details - The class action lawsuit is based on violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 [1]. - The class period for the lawsuit is from June 5, 2023, to February 8, 2024, with a deadline for participation set for April 7, 2026 [1]. - The complaint alleges that Masonite repurchased shares from investors while having knowledge of acquisition offers that would have significantly increased share prices [1]. Group 2: Investor Information - Shareholders who purchased shares during the class period are encouraged to contact the DJS Law Group for potential lead plaintiff appointments, although this appointment is not necessary to participate in any recovery [1]. - The DJS Law Group specializes in securities class actions and aims to enhance investor returns through advocacy and counseling [1].

Core Viewpoint - Kyndryl Holdings, Inc. is facing a class action lawsuit for securities law violations, specifically for making false and misleading statements regarding its financial performance and internal controls during the class period from August 7, 2024, to February 9, 2026 [1]. Group 1: Lawsuit Details - The lawsuit alleges that Kyndryl's financial statements were misstated throughout the class period, leading to materially misleading public statements [1]. - The deadline for shareholders to participate in the lawsuit is April 13, 2026 [1]. - Shareholders who purchased shares during the specified class period are encouraged to contact the DJS Law Group for potential lead plaintiff appointments [1]. Group 2: Company Background - Kyndryl Holdings, Inc. is listed on the NYSE under the ticker symbol KD [1]. - The DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and alternative asset managers [1].

PayPal Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before April 20, 2026 to Discuss Your Rights - PYPL [Accessibility Statement] Skip NavigationNEW YORK, Feb. 19, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of PayPal Holdings, Inc. (NASDAQ: PYPL).Shareholders who purchased shares of PYPL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is no ...